Learn more

MOMENTA PHARMACEUTICALS INC

Overview
  • Total Patents
    534
  • GoodIP Patent Rank
    6,262
  • Filing trend
    ⇩ 2.0%
About

MOMENTA PHARMACEUTICALS INC has a total of 534 patent applications. It decreased the IP activity by 2.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are IMMUNOQURE AG, SYNTIMMUNE INC and DANA FABER CANCER INST INC.

Patent filings per year

Chart showing MOMENTA PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bosques Carlos J 170
#2 Lansing Jonathan C 85
#3 Collins Brian Edward 72
#4 Ortiz Daniel 70
#5 Venkataraman Ganesh 69
#6 Shriver Zachary 64
#7 Ling Leona E 53
#8 Bulik Dorota A 51
#9 Parsons Ian Christopher 51
#10 Roy Sucharita 47

Latest patents

Publication Filing date Title
WO2021055876A1 COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CD38
WO2021022249A1 Fcrn antibodies and methods of use thereof
WO2020215021A1 Sialylated glycoproteins
WO2020142275A1 Methods of producing ustekinumab
WO2020077298A1 Treatment with highly silylated igg compositions
WO2020051042A1 Methods of continuous cell culture
US2020110095A1 Methods of protein interaction analysis
AU2019312139A1 Compositions of FcRn antibodies and methods of use thereof
SG11202100419UA Fcrn antibody compositions
WO2020014542A2 Compositions and methods related to engineered fc-antigen binding domain constructs
AU2019300020A1 Compositions and methods related to engineered Fc-antigen binding domain constructs
CA3106108A1 Compositions and methods related to engineered fc-antigen binding domain constructs targeted to pd-l1
WO2020014526A2 Compositions and methods related to engineered fc-antigen binding domain constructs targeted to cd38
WO2020014486A1 Compositions and methods related to engineered fc-antigen binding domain constructs
WO2020014505A2 COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS
CA3106207A1 Compositions and methods related to engineered fc-antigen binding domain constructs targeted to ctla-4
CA3105985A1 Compositions and methods related to engineered fc-antigen binding domain constructs targeted to ccr4
WO2019210306A1 Blood preparation
WO2019118791A1 Fcrn antibodies and methods of use thereof
WO2019060330A1 Methods for predicting response to treatment